GR 231118 (CAS 158859-98-4)

GR 231118 is a synthetic compound known for its role as a selective antagonist and partial agonist for the neurokinin-1 (NK1) and neurokinin-2 (NK2) receptors, respectively. These receptors are part of the tachykinin receptor family, which primarily bind neuropeptides like substance P and neurokinin A, involved in mediating various physiological responses including inflammation, pain perception, and vascular responses. GR 231118 has been particularly instrumental in research focusing on the neurochemical pathways of pain and inflammation. By blocking the NK1 receptor, GR 231118 inhibits the binding of substance P, a neuropeptide associated with pain transmission and inflammatory processes, thereby providing insights into potential mechanisms for new analgesic and anti-inflammatory drugs. Its partial agonistic effect on NK2 receptors, which primarily interact with neurokinin A, allows researchers to explore the balance between receptor inhibition and activation, offering a nuanced understanding of receptor dynamics in biological systems. This dual functionality makes GR 231118 a valuable tool in neuropharmacological research, aiding in the elucidation of complex signaling pathways that can lead to novel therapeutic strategies for managing pain and inflammatory diseases, strictly within a research context without implying clinical or pharmaceutical applications.